Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

Historical Holders from Q2 2017 to Q1 2025

Symbol
VRNA on Nasdaq
CUSIP
925050106
Type / Class
Equity / Ordinary Shares, nominal value GBP0.05 per share
Shares outstanding
87.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
68.6M
Holdings value
$3.19B
% of all portfolios
0.016%
Grand Portfolio weight change
+0%
Number of holders
197
Number of buys
103
Number of sells
-70
Average Value change %
0%
Average buys %
+0.005%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Growth Equity Opportunities Fund IV, LLC 4.99% $2.07B 32.7M Scott D. Sandell Jan 16, 2025
MAVERICK CAPITAL LTD 3.8% $1.59B 25M Maverick Capital, Ltd. Dec 31, 2024
RA CAPITAL MANAGEMENT, L.P. 8.9% $494M 7.78M RA Capital Management, L.P. Dec 31, 2024

Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 311K $19.7M +$4.38M $63.49 15
2024 Q4 68.6M $3.19B +$46.1M $46.44 197
2024 Q3 67.7M $1.95B +$158M $28.77 150
2024 Q2 65.8M $952M -$14.9M $14.46 125
2024 Q1 66.9M $1.08B -$14.9M $16.09 113
2023 Q4 67.1M $1.34B +$7.18M $19.88 113
2023 Q3 64.9M $1.07B +$34.8M $16.30 98
2023 Q2 62.6M $1.33B +$49.5M $21.14 101
2023 Q1 60.3M $1.21B +$167M $20.08 90
2022 Q4 50.1M $1.31B +$110M $26.13 85
2022 Q3 51.8M $529M +$183M $10.22 64
2022 Q2 34.8M $146M -$8.61M $4.19 36
2022 Q1 36.4M $182M -$2.54M $4.99 38
2021 Q4 36.9M $248M +$379K $6.72 41
2021 Q3 37M $203M +$753K $5.48 38
2021 Q2 36.7M $240M +$947K $6.54 35
2021 Q1 36.5M $305M +$6.93M $8.36 37
2020 Q4 35.7M $246M +$8.1M $7.00 34
2020 Q3 34.1M $213M +$168M $6.24 28
2020 Q2 7.17M $33.6M +$912K $4.68 18
2020 Q1 6.98M $28.8M +$4.64M $4.12 14
2019 Q4 5.85M $33.7M +$46.4K $5.75 13
2019 Q3 5.86M $26.8M -$7.63M $4.57 12
2019 Q2 7.37M $37.6M -$77.8K $5.10 16
2019 Q1 7.38M $47.5M -$1.63M $6.50 17
2018 Q4 8.41M $78.6M -$2.82M $9.05 17
2018 Q3 7.38M $92.3M +$11M $12.51 14
2018 Q2 5M $68.3M -$1.25M $13.66 12
2018 Q1 6.58M $132M -$1.92M $20.00 14
2017 Q4 6.68M $79.3M +$6.21M $11.87 10
2017 Q3 5.28M $81M +$20.7M $15.35 9
2017 Q2 3.95M $46.1M +$46.1M $11.66 9